Cargando…

Clinical efficacy of Chinese herbs for supplementing qi and activating blood circulation combined with N-acetylcysteine in the treatment of idiopathic pulmonary fibrosis: A systematic review and network meta-analysis

BACKGROUND: Chinese herbs for supplementing qi and activating blood circulation (CH) combined with N-acetylcysteine (NAC) is widely used for idiopathic pulmonary fibrosis (IPF) in China, but there is a lack of literature to evaluate its efficacy and clinical value. PURPOSE: This study compared CH +...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pang, Qinglu, Li, Guodong, Cao, Fang, Liu, Haoge, Wei, Wan, Jiao, Yang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8896725/ https://www.ncbi.nlm.nih.gov/pubmed/35245333 http://dx.doi.org/10.1371/journal.pone.0265006

Ejemplares similares

Number 2 Feibi Recipe Ameliorates Pulmonary Fibrosis by Inducing Autophagy Through the GSK-3β/mTOR Pathway
por: Liu, Haoge, et al.
Publicado: (2022)

Effects and mechanisms of pirfenidone, prednisone and acetylcysteine on pulmonary fibrosis in rat idiopathic pulmonary fibrosis models
por: Yu, Wencheng, et al.
Publicado: (2016)

Chinese herbal medicines compared with N-acetylcysteine for the treatment of idiopathic pulmonary fibrosis: Protocol for a systematic review
por: Guo, Jing, et al.
Publicado: (2018)

The Chinese Herb Yi-Qi-Huo-Xue Protects Cardiomyocyte Function in Diabetic Cardiomyopathy
por: Wang, Xiangsheng, et al.
Publicado: (2018)

Efficacy of N-Acetylcysteine in Idiopathic Pulmonary Fibrosis: A Systematic Review and Meta-Analysis
por: Sun, Tong, et al.
Publicado: (2016)

Efficacy of N-acetylcysteine plus pirfenidone in the treatment of idiopathic pulmonary fibrosis: a systematic review and meta-analysis
por: Zhang, Xiu-Li, et al.
Publicado: (2023)

Chinese Herbal Medicines Compared with N-Acetylcysteine for the Treatment of Idiopathic Pulmonary Fibrosis: A Systematic Review of Randomized Controlled Trials
por: Guo, Jing, et al.
Publicado: (2019)

Pharmacological treatment of idiopathic pulmonary fibrosis – preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine
por: Myllärniemi, Marjukka, et al.
Publicado: (2015)

Efficacy and safety of N-acetylcysteine therapy for idiopathic pulmonary fibrosis: An updated systematic review and meta-analysis
por: Feng, Fanchao, et al.
Publicado: (2019)

Screening Five Qi-Tonifying Herbs on M2 Phenotype Macrophages
por: Jiang, Yi-Xin, et al.
Publicado: (2019)

Exploring the Biochemical Basis of the Meridian Tropism Theory for the Qi-Invigorating Traditional Chinese Medicine Herb Panax ginseng
por: Li, Mengmei, et al.
Publicado: (2021)

Comparison of Longevity in Patients with Idiopathic Pulmonary Fibrosis Using Pirfenidone Versus Triple Therapy with Prednisolone, Azathioprine, and Acetylcysteine
por: Asl, Mobin Soleimanian, et al.
Publicado: (2023)

Efficacy of TCM therapy of tonifying lung–kidney's Qi-deficiency in a case of idiopathic pulmonary fibrosis: A case report
por: Chen, Ming-Jun, et al.
Publicado: (2019)

QiShenYiQi pill improves the reparative myocardial fibrosis by regulating autophagy
por: Lv, Shichao, et al.
Publicado: (2020)

Rapid detection of circulating fibrocytes by flowcytometry in idiopathic pulmonary fibrosis
por: Alhamad, Esam H., et al.
Publicado: (2015)

Altered epigenetic features in circulating nucleosomes in idiopathic pulmonary fibrosis
por: Guiot, J., et al.
Publicado: (2017)

Circulating fibrocytes are not disease-specific prognosticators in idiopathic pulmonary fibrosis
por: Stewart, Iain D., et al.
Publicado: (2021)

Molecular Mechanisms Underlying Qi-Invigorating Effects in Traditional Medicine: Network Pharmacology-Based Study on the Unique Functions of Qi-Invigorating Herb Group
por: Tran, Minh Nhat, et al.
Publicado: (2022)

Astragaloside IV Synergizing with Ferulic Acid Ameliorates Pulmonary Fibrosis by TGF-β1/Smad3 Signaling
por: Tong, Jiahuan, et al.
Publicado: (2021)

The Anti-Inflammatory Effects of Invigorating Kidney and Supplementing Qi Chinese Herbal Formulae in Asthma Patients
por: Kong, Lingwen, et al.
Publicado: (2017)

QiShenYiQi Attenuates Renal Interstitial Fibrosis by Blocking the Activation of β-Catenin
por: Zhou, Zhanmei, et al.
Publicado: (2016)

Identifying roles of “Jun-Chen-Zuo-Shi” component herbs of QiShenYiQi formula in treating acute myocardial ischemia by network pharmacology
por: Wu, Leihong, et al.
Publicado: (2014)

538. The Role of N-acetylcysteine on Post Covid-19 Pulmonary Fibrosis
por: Demot, Bernard, et al.
Publicado: (2021)

Increased circulating desmosine and age-dependent elastinolysis in idiopathic pulmonary fibrosis
por: de Brouwer, Bart, et al.
Publicado: (2018)

Do Circulating Monocytes Promote and Predict Idiopathic Pulmonary Fibrosis Progression?
por: Fernandez, Isis E., et al.
Publicado: (2021)

Calycosin Ameliorates Bleomycin-Induced Pulmonary Fibrosis via Suppressing Oxidative Stress, Apoptosis, and Enhancing Autophagy
por: Liu, Haoge, et al.
Publicado: (2022)

Autophagy in Idiopathic Pulmonary Fibrosis
por: Patel, Avignat S., et al.
Publicado: (2012)

Exploring the comorbidity mechanisms between asthma and idiopathic pulmonary fibrosis and the pharmacological mechanisms of Bu-Shen-Yi-Qi decoction therapy via network pharmacology
por: Zhong, Yuanyuan, et al.
Publicado: (2022)

Small airway dysfunction in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

N-Acetylcysteine attenuated pulmonary fibrosis induced by bleomycin via immunomodulation responses
por: Maghsadi, Zahra, et al.
Publicado: (2023)

Idiopathic pulmonary fibrosis associated with circulating autoantibodies: a Chinese cohort of a long-term follow-up study
por: Wang, Hui, et al.
Publicado: (2022)

Idiopathic pulmonary fibrosis
por: Meltzer, Eric B, et al.
Publicado: (2008)

Idiopathic Pulmonary Fibrosis
por: Lynch, Joseph P., et al.
Publicado: (2011)

Curcumin induced oxidative stress attenuation by N-acetylcysteine co-treatment: a fibroblast and epithelial cell in-vitro study in idiopathic pulmonary fibrosis
por: Rodriguez, L. R., et al.
Publicado: (2019)

Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis
por: Ziora, Dariusz, et al.
Publicado: (2015)

Nashville Qi? Chinese Medicine in an American Heartland
por: Rogaski, Ruth
Publicado: (2023)

Identification and immune characteristics of molecular subtypes related to fatty acid metabolism in idiopathic pulmonary fibrosis
por: Yang, Fan, et al.
Publicado: (2022)

External validation of the GAP model in Chinese patients with idiopathic pulmonary fibrosis
por: Zhang, Xinran, et al.
Publicado: (2022)

N-acetylcysteine tiherapeutically protects against pulmonary fibrosis in a mouse model of silicosis
por: Huang, Huaping, et al.
Publicado: (2019)

Comparison of Pharmacokinetics and Anti-Pulmonary Fibrosis-Related Effects of Sulforaphane and Sulforaphane N-acetylcysteine
por: Son, Eun Suk, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s4ctjhafg792dn7eqjuol03csh